Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Operating Expenses | 13,057 | 11,057 | 9,005 | 6,835 | 6,138 |
| Operating Income | -13,057 | -11,057 | -9,005 | -6,835 | -6,138 |
| Other Income | 116 | -295 | -294 | 56 | -279 |
| Pre-tax Income | -12,941 | -11,352 | -9,299 | -6,779 | -6,417 |
| Net Income Continuous | -12,941 | -11,352 | -9,299 | -6,779 | -6,417 |
| Net Income | $-12,941 | $-11,352 | $-9,299 | $-6,779 | $-6,417 |
| EPS Basic Total Ops | -3.20 | -4.10 | -13.00 | -9.70 | -9.40 |
| EPS Basic Continuous Ops | -3.18 | -4.15 | -12.99 | -9.69 | -9.41 |
| EPS Diluted Total Ops | -3.20 | -4.10 | -13.00 | -9.70 | -9.40 |
| EPS Diluted Continuous Ops | -3.18 | -4.15 | -12.99 | -9.69 | -9.41 |
| EBITDA(a) | $-12,814 | $-10,815 | $-8,677 | $-6,484 | $-6,039 |